Tersera Therapeutics LLC

IL · United States · Reporting entity ID 100000181761

Total reported 2019–2025

$10.5M

#477 of 2,960 reporting companies — 0% of all reported industry payments

$4.93M in general payments across 33,813 records, plus $3.78M in research funding across 495 records.

How it breaks down

General payments $4,928,579

Research funding $3,779,086

Ownership & investment $1,778,328

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.